NCT04172259 2023-10-16
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
Sun Yat-sen University
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT05346107 2022-04-26
PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer
Xijing Hospital
Phase 2 Unknown
NCT03949634 2019-05-14
Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)
Fudan University
Phase 3 Unknown